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The biological sensitivity of cultured non-rheumatoid human synovial cells (NRSCs) and rheumatoid syno- 
vial cells (RSCs) was examined in terms of the ability of insulin to stimulate the uptake of ct-aminoisobutyr- 
ate (AIB). NRSCs, like numerous fibroblastic lines, were sensitive to physiological concentrations of the 
hormone: half-maximal stimulation was obtained with (4 x 10 10 M) insulin, while maximum transport was 
found with a 60-90 min association time. On the contrary, although the basal transport was similar in RSCs, 
insulin was totally unable to accelerate AIB transport in these cells. Inflammatory processes lead to an insu- 
lin resistance which most likely involves a post-receptor step at the cellular level. 
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1. INTRODUCTION 
Synoviocytes are fibroblastic ells which might 
undergo metabolic modifications during inflam- 
matory processes such as rheumatoid arthritis, 
through a stimulation by numerous oluble factors 
or local hormones [1-3]. In a recent paper we 
described modifications in the initial step of 
rheumatoid cell culture, i.e. attachment and 
spreading [4]. On the other hand, the specific 
ligands which arrive at the synovial membrane via 
the blood stream have largely been ignored apart 
from the work of Goldring et al. [5] on the 
parathyroid hormone. Insulin was chosen with a 
view to investigating synoviocyte sensitivity to cir- 
culating hormones. Insulin is known to stimulate 
amino acid transport in fibroblasts [6,7] through 
system A [8]. The cr-aminoisobutyrate (AIB) up- 
take process was thus studied in synoviocytes and 
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the influence of acute inflammation states on AIB 
transport with regard to insulin was investigated. 
2. MATERIALS AND METHODS 
2.1. Materials 
Dulbecco's modified Eagle's medium (DMEM), 
fetal calf serum (FCS), glutamine, bicarbonate, 
trypsin, phosphate buffered saline (PBS) were pur- 
chased from Eurobio (Paris, France). Clostridia 
collagenase (type II) and bovine pancreas insulin 
were from Sigma (St. Louis, USA). a,- 
[1-14C]Aminoisobutyrate (spec. act. 57 mCi/ 
mmol) was obtained from CEA (Saclay, France). 
2.2. Cell cultures 
Synovial cells were isolated from samples of 
knee synovium obtained at synovectomy from pa- 
tients with either osteoarthritic joint disease or 
clinically and biologically confirmed rheumatoid 
arthritis. Patients presented neither diabetes nor 
clinical insulin resistance. Synovial cell cultures 
were prepared using a proteolytic procedure as 
described [4]. When cellular confluence was attain- 
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ed, a passage was carried out using trypsin. 7 x 10 4 
cells were suspended in 2 ml of  DMEM plus 4.8% 
bicarbonate and 2% glutamine supplemented with 
10% FCS and placed in 9.6 cm 2 plastic dishes. 
Sub-conf luent cultures were used for cell ex- 
periments. 
2.3. AIB uptake 
The experiment was carried out as described [9]. 
Briefly, to reduce the intracel lular pool  of  amino 
acids and thus minimise possible trans-effects [10], 
the cells were placed for 1 h in depletion medium, 
i.e. PBS alone or with effector. Cells were then in- 
cubated for 10 min in PBS containing 8/~M 
(0.5/zCi /ml)  [14C]AIB. Cells were dissolved in 1 M 
NaOH,  radioact iv i ty was counted, and protein 
content measured by the Lowry method [11]. The 
results were expressed as cpm/mg protein per 
10 min. 
2.4. Statistics 
Data are given as means + SD of  tr ipl icate 
measurements.  Compar isons were made by use of  
a non-parametr ic  one-way analysis of  variance ac- 
cording to Kruskal l -Wal l is  test [12]. 
3. RESULTS 
To evaluate the sensitivity and responsiveness of
human non-rheumato id  (NRSCs) and rheumatoid 
synovial cells (RSCs) to insulin, the biological 
response to the hormone was analyzed by perform- 
ing dose-response curves and time courses of  in- 
sulin action. 
3.1. Dose-response curves for insulin 
Sub-conf luent cultures of  human synovial cells 
were incubated at 37°C with various concentra- 
tions of  bovine insulin (1.7 x 10 -1° to 1.7 x 
10 -7 M) .  The associat ion time in the presence of  
insulin was 1 h, since we have previously found 
that this t ime allows the maximal  st imulat ion ef- 
fect of  A IB uptake in f ibroblasts [13]. The data for 
A IB  uptake by NRSCs are given in fig.1. The 
transport  rate was signif icantly higher than in con- 
trois f rom 1.7 x 10 -9 to 1.7 x 10 -7 M insulin and 
from 1.7 x 10 -8 to 1.7 x 10 -7 M insulin in the two 
cell cultures, GE.M.  and TE. J . ,  respectively. The 
maximum st imulat ion was obtained between 1.7 x 
lo~ cpm/rng protein / lornin I 
3-  
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Fig.1. Dose responses of insulin stimulation of AIB 
transport in donor GE.M (e) and donor TE.J ( I )  of 
NRSCs. Each point is the mean _+ SD of triplicate 
determinations. * p < 0.05, ** p < 0.02, *** p < 0.01 
and **** p < 0.001 compared to basal uptake. 
lo3,¢pm/rng protein/lomin 
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Fig.2. Dose responses of insulin stimulation of AIB 
transport in donor MO.J (e), donor MI.A (A) and 
donor VU.C ( I )  of RSCs. Each point is the mean _+ SD 
of triplicate determinations. 
10 -9 M and 1.7 x 10 -8 M insulin, corresponding 
to a 60% increase over basal uptake. The NRSCs 
were sensitive to the action of  insulin with half- 
maximal  st imulat ion at a hormone concentrat ion 
of  approx.  4 x 10 -1° M. In the cultures from three 
rheumatoid donors,  A IB  uptake was not 
st imulated whatever the concentrat ion of  insulin 
used (fig.2). 
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Table 1 
Time course of insulin effect on AIB uptake in NRSCs and RSCs 
April 1987 
Cell 
cultures Time (min) 
0 30 60 90 120 
NRSC 5505 ± 455 6763 ± 343 8058 ± 576** 8488 ± 451"* 7940 ± 450* 
RSC 3754 ± 390 4566 ± 620 3168 ± 502 3412 ± 416 3230 ± 426 
Each point is the mean _+ SD of triplicate determination. *p < 0.01 and **p < 0.001 
compared to control. NRSCs were from donor PA.C and RSC from donor RS.A 
3.2. Time courses o f  insulin effect 
For these experiments, a physiological 
stimulating insulin concentration (1,7 × 10 -9 M) 
was used. Results are given in table 1. 
In NRSCs, AIB uptake stimulation was obtain- 
ed after 60 min, but the insulin effect gradually in- 
creased to a maximum at 90 min (+ 52°7o of basal 
uptake) when a steady state was reached. 
In RSCs, insulin treatment at various associa- 
tion times had no effect on AIB uptake. 
4. DISCUSSION 
The present study provides evidence that insulin 
at concentrations within physiological values 
stimulates the uptake of AIB in NRSCs. This 
observation is in agreement with previous reports 
on the insulin effect on AIB uptake in human 
fibroblasts [14,15]. The hormone-mediated 
stimulatory effect was detected after a 60 rain ex- 
posure of the synoviocytes to the hormone, but 
was only fully expressed 1 V2h later. It is well 
known that insulin enhances amino acid uptake 
through mRNA and protein synthesis-dependent 
processes [7]. It appears that the sensitivity and 
responsiveness of synoviocytes to the hormone 
(half-maximum response 4 x 10 -1° M, stimulation 
+ 60°70) were quite similar to numerous reports in 
the literature [14-16]. 
The basal transport of AIB varied in the dif- 
ferent experiments. However, the mean basal 
transport in NRSCs and RSCs was not significant- 
ly different. The AIB transport system can be con- 
sidered as thus similar in NRSCs and RSCs. Our 
results are in disagreement with those of Byers et 
al. [17] who showed a decrease in amino acid 
transport induced by inflammation in chon- 
drocytes. However, their experiments were per- 
formed using rabbit articular cartilage tissue, not 
cell cultures after in vivo treatment with car- 
rageenin. 
We have shown impaired insulin action in 
cultured synovial cells from patients with 
rheumatoid arthritis. These results cannot be 
.related to any clinical state of insulin resistance 
such as leprechaunism [15], diabetes [18] or 
pregnancy [19]. Moreover, the interference of 
drugs such as aspirin or glucocorticoids which in- 
duce insulin resistance [20,21] appears unlikely; in 
effect, it was removed uring the various steps of 
the culture. In RSCs, we observed a combination 
of a lack of sensitivity and responsiveness to in- 
sulin, whatever the rheumatoid patient. Insulin 
resistance at the cellular level is due to an alteration 
at a pre-receptor, eceptor or post-receptor level. 
As insulin resistance at the pre-receptor level 
would involve a factor reducing the free insulin 
concentration, we verified that RSC culture 
medium did not release an insulin degrading pro- 
teolytic enzyme (not shown). At the membrane 
level, alterations in receptor affinity or concentra- 
tion could also result in a decreased sensitivity to 
the hormone. We have demonstrated (submitted) 
that the number and the affinity of insulin recep- 
tors were similar in NRSCs and RSCs. This implies 
that the anomaly exists at the post-receptor step, 
preventing the hormone from increasing either the 
velocity of translocation of amino acids across the 
membrane or the turnover of carriers [22]. 
In conclusion, these findings indicate a normal 
biological effect of insulin in NRSCs and a specific 
defect in RSCs involving a decreased sensitivity 
329 
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and an unresponsiveness to the hormone. These 
data will be of use in the interpretation of future 
work on RSCs with regard to the biological effects 
of polypeptide hormones. 
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